Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 1
1993 1
1994 1
1998 1
1999 1
2000 3
2001 1
2002 1
2004 1
2007 3
2008 1
2009 6
2010 1
2011 4
2012 3
2013 1
2014 2
2015 2
2016 4
2017 4
2018 4
2019 3
2020 6
2021 6
2022 4
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Disease-related malnutrition with inflammation and cachexia.
Muscaritoli M, Imbimbo G, Jager-Wittenaar H, Cederholm T, Rothenberg E, di Girolamo FG, Amabile MI, Sealy M, Schneider S, Barazzoni R, Biolo G, Molfino A. Muscaritoli M, et al. Among authors: imbimbo g. Clin Nutr. 2023 Aug;42(8):1475-1479. doi: 10.1016/j.clnu.2023.05.013. Epub 2023 May 18. Clin Nutr. 2023. PMID: 37302879 Free article.
A critical appraisal of blood-based biomarkers for Alzheimer's disease.
Lista S, Mapstone M, Caraci F, Emanuele E, López-Ortiz S, Martín-Hernández J, Triaca V, Imbimbo C, Gabelle A, Mielke MM, Nisticò R, Santos-Lozano A, Imbimbo BP. Lista S, et al. Among authors: imbimbo bp, imbimbo c. Ageing Res Rev. 2024 Apr;96:102290. doi: 10.1016/j.arr.2024.102290. Epub 2024 Apr 4. Ageing Res Rev. 2024. PMID: 38580173 Review.
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?
Lista S, Imbimbo BP, Grasso M, Fidilio A, Emanuele E, Minoretti P, López-Ortiz S, Martín-Hernández J, Gabelle A, Caruso G, Malaguti M, Melchiorri D, Santos-Lozano A, Imbimbo C, Heneka MT, Caraci F. Lista S, et al. Among authors: imbimbo bp, imbimbo c. J Neuroinflammation. 2024 Jul 30;21(1):187. doi: 10.1186/s12974-024-03163-y. J Neuroinflammation. 2024. PMID: 39080712 Free PMC article. Review.
Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?
Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Santamato A, Lozupone M, Capozzo R, Prete C, Pilotto A, Greco A, Logroscino G. Panza F, et al. Among authors: imbimbo bp. Expert Opin Pharmacother. 2016;17(4):457-61. doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15. Expert Opin Pharmacother. 2016. PMID: 26809554 No abstract available.
Disease-modifying therapies for tauopathies: agents in the pipeline.
Panza F, Imbimbo BP, Lozupone M, Greco A, Seripa D, Logroscino G, Daniele A, Colosimo C. Panza F, et al. Among authors: imbimbo bp. Expert Rev Neurother. 2019 May;19(5):397-408. doi: 10.1080/14737175.2019.1606715. Epub 2019 Apr 25. Expert Rev Neurother. 2019. PMID: 30973276 Review.
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma.
Chiffelle J, Barras D, Pétremand R, Orcurto A, Bobisse S, Arnaud M, Auger A, Rodrigo BN, Ghisoni E, Sauvage C, Saugy D, Michel A, Murgues B, Fahr N, Imbimbo M, Ochoa de Olza M, Latifyan S, Crespo I, Benedetti F, Genolet R, Queiroz L, Schmidt J, Homicsko K, Zimmermann S, Michielin O, Bassani-Sternberg M, Kandalaft LE, Dafni U, Corria-Osorio J, Trueb L, Dangaj Laniti D, Harari A, Coukos G. Chiffelle J, et al. Among authors: imbimbo m. Immunity. 2024 Sep 10:S1074-7613(24)00413-8. doi: 10.1016/j.immuni.2024.08.014. Online ahead of print. Immunity. 2024. PMID: 39276771
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.
Lo Russo G, Pusceddu S, Prinzi N, Imbimbo M, Proto C, Signorelli D, Vitali M, Ganzinelli M, Maccauro M, Buzzoni R, Seregni E, de Braud F, Garassino MC. Lo Russo G, et al. Among authors: imbimbo m. Tumour Biol. 2016 Oct;37(10):12991-13003. doi: 10.1007/s13277-016-5258-9. Epub 2016 Jul 27. Tumour Biol. 2016. PMID: 27460087 Review.
Well-differentiated bronchial neuroendocrine tumors (B-NETs) are rare. They represent 1-5 % of all lung cancers. The incidence of these neoplasms has risen over the past 30 years and, especially for advanced or metastatic disease, management is complex and requires a multi …
Well-differentiated bronchial neuroendocrine tumors (B-NETs) are rare. They represent 1-5 % of all lung cancers. The incidence of the …
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Rusakiewicz S, Tyekucheva S, Tissot-Renaud S, Chaba K, Imbimbo M, Benedetti F, Kammler R, Hornfeld J, Munzone E, Gianni L, Thurlimann B, Láng I, Pruneri G, Gray KP, Regan MR, Loi S, Colleoni M, Viale G, Kandalaft L, Coukos G, Curigliano G. Rusakiewicz S, et al. Among authors: imbimbo m. Eur J Cancer. 2024 Mar;200:113535. doi: 10.1016/j.ejca.2024.113535. Epub 2024 Jan 24. Eur J Cancer. 2024. PMID: 38309015
67 results